
Sign up to save your podcasts
Or


Send us a text
Reviewing press releases reporting preliminary findings from six recently announced Phase 2 trials
Stephen Harrison leads the Surfers, with guest Louise Campbell, through an examination of six Phase 2 clinical trials that put forth press releases during the last three months. In all, the discussion created an air of optimism based on better clinical outcomes than we have seen with earlier NASH drugs, all from medicines with distinct but potentially complementary modes of action.
By SurfingNASH.com3.9
2424 ratings
Send us a text
Reviewing press releases reporting preliminary findings from six recently announced Phase 2 trials
Stephen Harrison leads the Surfers, with guest Louise Campbell, through an examination of six Phase 2 clinical trials that put forth press releases during the last three months. In all, the discussion created an air of optimism based on better clinical outcomes than we have seen with earlier NASH drugs, all from medicines with distinct but potentially complementary modes of action.

32,309 Listeners

30,778 Listeners

9,758 Listeners

104 Listeners

21,256 Listeners

3,378 Listeners

113,432 Listeners

56,986 Listeners

9,576 Listeners

8,685 Listeners

10,279 Listeners

6,472 Listeners

0 Listeners

419 Listeners

683 Listeners